...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Idea for Zenith
3
Jul 13, 2021 07:39PM
2
Jul 14, 2021 08:25AM
8
Jul 14, 2021 10:03AM
1
Jul 14, 2021 10:48AM
2
Jul 14, 2021 11:07AM
3
Jul 14, 2021 11:17AM
4
Jul 14, 2021 11:48AM
4
Jul 16, 2021 12:55PM
2
Jul 16, 2021 02:51PM

the "ZHCLF" shares trading on the OTC, do they carry with them the Resverlogix Royalty Preferred Shares that are entitled to dividends in the amount of 6-12 % of Resverlogix's net revenue if any.

Any shares that trade are just moving from one person to another so they would carry any rights with them.

 

3
Jul 25, 2021 08:35PM
Share
New Message
Please login to post a reply